Patakas D, Vlachoianni E, Tsara V, Louridas G, Argiropoulou P
J Allergy Clin Immunol. 1983 Sep;72(3):269-73. doi: 10.1016/0091-6749(83)90031-3.
In 11 patients with bronchial asthma and regular overnight falls in PEFR of greater than 15%, we demonstrated significant bronchodilation restricted only to large airways after the administration of a single dose of 10 mg of nifedipine. A statistically significant increase in PEFR, SGaw, and FEV1 was noticed at 1 and especially 2 hr after nifedipine administration. During 4 days of nifedipine treatment (10 mg t.i.d.), the overnight fall in mean PEFR was statistically significant (p less than 0.02) and less than the mean fall of PEFR during the 4 days of placebo treatment. Thus nifedipine does modify the basal bronchial tone of patients with asthma and diminishes the circadian swing of airway resistance.
在11例支气管哮喘患者中,其呼气峰流速(PEFR)夜间规律性下降超过15%,我们发现单次给予10毫克硝苯地平后,显著的支气管扩张仅局限于大气道。硝苯地平给药后1小时尤其是2小时,PEFR、比气道传导率(SGaw)和第一秒用力呼气容积(FEV1)有统计学意义的增加。在硝苯地平治疗4天(10毫克,每日三次)期间,平均PEFR的夜间下降有统计学意义(p小于0.02),且低于安慰剂治疗4天期间PEFR的平均下降幅度。因此,硝苯地平确实改变了哮喘患者的基础支气管张力,并减少了气道阻力的昼夜波动。